ライフサイエンスコーパス: green monkey

1 estrogen-replaced nonhuman primates (African green monkeys).

2 ces were obtained for cynomolgus macaque and green monkey.

3 otype 3 (SFVagm-3), isolated from an African green monkey.

4 -3-fold higher in cynomolgus monkeys than in green monkeys.

5 sterol levels were 50% lower than was fed to green monkeys.

6 CAT2 mRNA nor protein was diet-responsive in green monkeys.

7 ary cholesterol, and less responsive African green monkeys.

8 simian immunodeficiency viruses from African green monkeys.

9 tralization titers in RSV-preexposed African green monkeys.

10 vet, grivet, and tantalus species of African green monkeys.

11 nted in the striatum of MPTP-treated African green monkeys.

12 n the dorsal and ventral striatum of African green monkeys.

13 candidates after a single passage in African green monkeys.

14 immunodeficiency virus infections of African Green Monkeys.

15 both LDL receptor-deficient mice and African green monkeys.

16 g natural SIV variants isolated from African green monkeys.

17 DSS treatment of SIV-infected African green monkeys, a natural host species for SIV that does

18 stration to the respiratory tract of African green monkeys, a permissive primate host.

19 uman A3C (hA3C), human A3DE (hA3DE), African green monkey A3F (agmA3F), and rhesus macaque A3F (rhA3F

20 V) Vif was shown to bind and degrade African green monkey A3G (agmA3G) and, unexpectedly, human A3C.

21 re, we report the DNA sequence of an African green monkey AAV integration site isolated from CV-1 cel

22 t rhesus macaque APOBEC3G (rhA3G) or African green monkey (AGM) APOBEC3G (agmA3G) because of a failur

23 for studying HeV infection, with the African green monkey (AGM) appearing to most faithfully reproduc

24 The present report reveals that African green monkey (AGM) cells, which contain extensive alpha-

25 within human cells that is absent in African green monkey (AGM) cells.

26 EC3G but does not block the mouse or African green monkey (AGM) enzyme.

27 mined the pathogenesis of HeV in the African green monkey (AGM) following intratracheal inoculation.

28 Here, an African green monkey (AGM) model was used to elucidate immune me

29 his issue, we established a neonatal African green monkey (AGM) nonhuman primate model that could be

30 sely, the Vif protein encoded by the African green monkey (agm) simian immunodeficiency virus (SIV) c

31 the A3G-Vif interaction within four African green monkey (AGM) subspecies, which are each naturally

32 ndogenous retroviruses produced from African green monkey (AGM) tissues or cell lines.

33 n, we isolated cDNA clones of human, African green monkey (AGM), and NIH/Swiss mouse CCR5s, and we qu

34 b from its natural host, the sabaeus African green monkey (AGM), to a new host, the pigtailed macaque

35 investigate replication in primates, African green monkeys (AGM) and rhesus macaques (n = 4) were ino

36 African green monkeys (AGM) and sooty mangabeys (SM) are well-st

37 Natural hosts, such as African green monkeys (AGM) and sooty mangabeys (SM), are protec

38 ection in its natural hosts, such as African green monkeys (AGM) and sooty mangabeys (SM).

39 African green monkeys (AGM) are natural hosts of simian immunode

40 African green monkeys (AGM) are natural hosts of SIV, and infect

41 African green monkeys (AGM) do not develop overt signs of diseas

42 were assessed in naturally infected African green monkeys (AGM) of the vervet subspecies (Chlorocebu

43 In contrast, both marmosets and African green monkeys (AGM) proved susceptible to aerosolized RV

44 genic differences between strains, 4 African green monkeys (AGM) were exposed to NiVM and 4 AGMs were

45 ssive infection (SIVagm infection of African green monkeys (AGM)), and transient, controlled infectio

46 impanzees, sooty mangabeys (SM), and African green monkeys (AGM).

47 range of African primates, including African green monkeys (AGM).

48 EHO and ALI), and one strain of SIV (African Green Monkey, AGM).

49 rulence in BALB/c mice, ferrets, and African green monkeys (AGMs) (Chlorocebus aethiops).

50 iral pathogens in two populations of African green monkeys (AGMs) (Chlorocebus sabaeus) from Africa a

51 nd in nonpathogenic SIV infection of African green monkeys (AGMs) and sooty mangabeys.

52 African green monkeys (AGMs) are a natural host of SIV that do n

53 geographically dispersed species of African green monkeys (AGMs) are all infected with highly divers

54 African green monkeys (AGMs) are natural hosts of simian immunod

55 African green monkeys (AGMs) are natural primate hosts of simian

56 African green monkeys (AGMs) are naturally infected with a simia

57 African green monkeys (AGMs) are naturally infected with simian

58 We used African green monkeys (AGMs) as a nonhuman primate (NHP) model f

59 the findings in humans and evaluated African green monkeys (AGMs) as a nonhuman primate model.

60 roximately 98-99% identical) CCR5 of African green monkeys (AGMs) avidly binds beta-chemokines and fu

61 est the hypothesis that SIV-infected African green monkeys (AGMs) avoid AIDS due to virus replication

62 Chronically SIVagm-infected African green monkeys (AGMs) have a remarkably stable nonpathoge

63 liciting a strong immune response in African green monkeys (AGMs) in a single dose.

64 fection in sooty mangabeys (SMs) and African green monkeys (AGMs) is associated with low levels of im

65 s of chronically SIV-infected sabeus African green monkeys (AGMs) revealed that gastrointestinal memo

66 d from pigtailed macaques (PTMs) and African green monkeys (AGMs) that experience different SIVsab in

67 d SIVsab from the sabaeus species of African green monkeys (AGMs) to pigtailed macaques (PTMs).

68 p of 10 rhesus macaques (RMs) and 10 African green monkeys (AGMs) was exposed to aerosolized B. pseud

69 Caribbean-born African green monkeys (AGMs) were classified as Chlorocebus saba

70 ans from chronically SIVagm-infected African green monkeys (AGMs) were frequently CXCR5(+) and entere

71 A small number of African green monkeys (AGMs) were introduced into the Caribbean

72 the respiratory tracts of hamsters, African green monkeys (AGMs), and chimpanzees.

73 dominantly in sooty mangabeys (SMs), African green monkeys (AGMs), and mandrills.

74 dominantly in sooty mangabeys (SMs), African green monkeys (AGMs), and mandrills.

75 n immunodeficiency virus SIVagm from African green monkeys (AGMs), do not encode Vpu.

76 In African green monkeys (AGMs), rHPIV1-P(C-) was considerably more

77 eficiency virus (SIV) hosts, such as African green monkeys (AGMs), sustain nonpathogenic SIV infectio

78 Unlike HIV-1-infected humans, African green monkeys (AGMs), the natural SIV host species, sust

79 and uninfected natural hosts of SIV, African green monkeys (AGMs), to that of RMs.

80 al days, in the respiratory tract of African green monkeys (AGMs).

81 ns were tested for immunogenicity in African green monkeys (AGMs).

82 uction and replicated efficiently in African green monkeys (AGMs).

83 and attenuated in mice, ferrets, and African green monkeys (AGMs).

84 te and chronic SIVagm replication in African green monkeys (AGMs).

85 African green monkeys (AGMs; genus Chlorocebus) are a natural ho

86 caques [PTMs]) and nonpathogenic (in African green monkeys [AGMs]) SIVsab infections to assess the si

87 lizing antibody titers obtained from African green monkeys and after human vaccination and natural in

88 strate that nonhuman primates (NHPs; African green monkeys and cynomolgus macaques) harbor serosal B

89 tified multiple SAMHD1 haplotypes in African Green Monkeys and find that the vpr gene from different

90 hosts (for example, sooty mangabeys, African green monkeys and mandrills) share many features of HIV

91 s used to disrupt CypA in cells from African green monkeys and rhesus macaques.

92 utcomes of SIVsab infection in PTMs, African green monkeys, and rhesus macaques are different, the us

93 ciently in the respiratory tracts of African green monkeys, and the infected animals developed a high

94 TRIM5alpha B30.2 domain v1 region of African green monkeys are also associated with broader antiretro

95 iency virus (SIVagm) Vif can inhibit African green monkey but not human Apo3G.

96 administered separately to groups of African green monkeys by the intranasal/intratracheal route.

97 African green monkeys can maintain long-term persistent infectio

98 ng activities expressed by human and African green monkey cell lines.

99 pr proteins are capable of arresting African green monkey cells but are completely inactive in human

100 chia coli and as a secreted protein from Cos green monkey cells was also investigated.

101 (RhTRS1) fulfills these functions in African green monkey cells, but not rhesus or human cells.

102 In African green monkey cells, HIV-1 virus-like particles ablate re

103 IgA did not inhibit HAV infection of African green monkey cells, suggesting that the IgA and the viru

104 n after entry into rhesus macaque or African green monkey cells, where, paradoxically, the interactio

105 e Lv1 activity in rhesus macaque and African green monkey cells.

106 ity could be demonstrated in cognate African green monkey cells.

107 African green monkeys (Cercopithecus aethiops sabaeus) were ovar

108 Four African green monkeys (Cercopithecus aethiops) were injected sub

109 s musculus), hamster (Mesocricetus auratus), green monkey (Ceropithecus aethiops) and human (Homo sap

110 Herein we report that two species of African green monkeys (Chlorocebus sabaeus and C. pygerythrus) i

111 cyte-depleting antibodies to sabaeus African green monkeys (Chlorocebus sabaeus) before challenge wit

112 herpesviruses recently identified in African green monkeys, Chlorocebus rhadinovirus types 1 and 2 (C

113 An African green monkey CMV UL32 homolog complemented DeltaUL32-BAC

114 d a range of restriction in mice and African green monkeys comparable with that of two attenuated RSV

115 duction in LNCaP cells as well as in African green monkey CV-1 cells.

116 Infection of African green monkey CV1 cells with SV40 resulted in the activat

117 rom chimpanzees] and SIVagmSab [from African green monkeys]) discordantly in different regions of the

118 nts from humans, rhesus monkeys, and African green monkeys displayed different but overlapping restri

119 e show that many CD4(+) T cells from African green monkeys downregulate CD4 in vivo as they enter the

120 ery atherosclerosis were examined in African green monkeys fed diets containing cholesterol and 35% o

121 We immunised eight African green monkeys, four with a single dose of BHPIV3/ SARS-S

122 128, previously shown to distinguish African green monkey from human APOBEC3G.

123 y shown that intranasal SV protected African green monkeys from challenge with the related human para

124 ruses (family Arteriviridae) in wild African green monkeys from Zambia (malbroucks [Chlorocebus cynos

125 Here, we discover two new viruses in African green monkeys from Zambia and South Africa.

126 African green monkeys (genus Chlorocebus) can be infected with s

127 In African green monkeys immunized intranasally and intratracheally

128 African green monkeys immunized through the respiratory tract wi

129 African green monkeys immunized with b/h PIV3 expressing either

130 uated the immunological responses of African green monkeys immunized with multiple F and G protein-ba

131 African green monkeys immunized with two doses of the vector exp

132 NDV-HA was administered to African green monkeys in two doses of 2 x 10(7) infectious units

133 d/nonprogressive infection) and from African green monkeys infected with SIVsab9315BR (nonpathogenic

134 set of clinical anthrax disease, the African green monkey is a suitable animal model exhibiting a dis

135 enuated viruses adapted to growth in African green monkey kidney (AGMK) and MRC-5 cells, respectively

136 natural function which serves as an African green monkey kidney (AGMK) cell receptor for HAV.

137 Serum-starved primary African green monkey kidney (AGMK) cells also showed decreased p

138 ntibodies raised against susceptible African green monkey kidney (AGMK) cells as probes.

139 ed from a cDNA expression library of African green monkey kidney (AGMK) cells by using protective mon

140 Hepatitis A virus (HAV) infects African green monkey kidney (AGMK) cells via the HAV cellular re

141 ar receptor 1 (havcr-1) and protects African green monkey kidney (AGMK) clone GL37 cells (GL37 cells)

142 Buffalo green monkey kidney (BGMK) cells expressing human DAF (B

143 sackievirus B6 replication in living Buffalo green monkey kidney (BGMK) cells via Tat peptide deliver

144 To characterize interactions between African green monkey kidney (BS-C-1) cell proteins and the predi

145 M175/P16, enhance growth in cultured African green monkey kidney (BS-C-1) cells but not in fetal rhes

146 Lytic infection of African green monkey kidney (CV-1) cells by simian virus 40 (SV4

147 and establishing stably transfected African green monkey kidney (CV1) cell lines expressing reporter

148 We found that the infection of African green monkey kidney (Vero) cells by vesicular stomatitis

149 , and produced very small plaques on African green monkey kidney (Vero) cells that were similar in si

150 N2, H5N1 and H7N9 vaccine viruses in African green monkey kidney and Madin-Darby canine kidney cells.

151 ibited vaccinia virus replication in African green monkey kidney BSC-40 cells.

152 s and deletions were monitored in an African green monkey kidney cell culture system (COS-7 cells) as

153 reliminary studies indicated that an African green monkey kidney cell line (Vero) is a suitable syste

154 rescue and growth properties in the African green monkey kidney cell line, Vero.

155 within a few cycles of infection in African green monkey kidney cell lines CV-1, CV-1P, TC-7, MA-134

156 generates H2O2, was introduced into African green monkey kidney cells (CV-1 cells) under the control

157 ell homeostasis were investigated in African green monkey kidney cells (CV-1) by assessing the appear

158 1.3, was heterologously expressed in African Green Monkey kidney cells (CV-1) using a vaccinia virus/

159 n U937 cells (histiocytic lymphoma), African green monkey kidney cells (MARC-145 and Vero), primary m

160 e microsurgically removed from BSC-1 African green monkey kidney cells before the completion of S pha

161 African green monkey kidney cells expressing pIgR demonstrated H

162 Hepatitis A virus (HAV) infects African green monkey kidney cells via HAV cellular receptor 1 (h

163 wing passage in C6/36 cells, primary African green monkey kidney cells, or Vero cells.

164 African green monkey kidney cells, Vero C1008, polarizable epith

165 lanoma cell line but not to the CV-1 African green monkey kidney cells, which express CD44 at low lev

166 dney, A549, rhabdomyosarcoma, and/or Buffalo green monkey kidney cells.

167 pendent viral translation in vivo in African green monkey kidney cells.

168 cells and CYP1A1- and AHR-deficient African green monkey kidney CV-1 cells.

169 Cytotoxicity was evaluated in green monkey kidney epithelial (Vero) cells and MT-4 leu

170 eir respective intracellular niches, African green monkey kidney epithelial (Vero) cells, A/J mouse b

171 tion was detected in only six: three African green monkey kidney epithelial cell lines (Vero, Vero E6

172 0 DNA replication in infected BSC-1 (African green monkey kidney epithelial) cells, albeit at a great

173 ve in 293T (embryonic kidney), Vero (African-green monkey kidney epithelial), 3T12 (mouse fibroblast)

174 interact with CD66a-transfected COS (African green monkey kidney) and CHO (Chinese hamster ovary) cel

175 COS7 (African Green Monkey kidney) cells stably transfected with the m

176 Using COS (African green monkey kidney) cells transfected with cDNAs encodi

177 CAT2 gene product was cloned from an African green monkey liver cDNA library.

178 In cynomolgus monkeys but not in green monkeys, liver free cholesterol concentrations wer

179 ferent species of naturally infected African green monkeys living in different regions across Africa.

180 , complete suppression of macaque or African green monkey Lv1 was achieved by the additive effect of

181 CXCR6 by SIVagmSab to infect sabaeus African green monkey lymphocytes.

182 natural SIV hosts (sooty mangabeys, African green monkeys, mandrills, sun-tailed monkeys, and chimpa

183 Eleven fetal African green monkey midbrains were immunostained for tyrosine h

184 ed the use of RSV (Memphis 37) in an African green monkey model of intranasal infection and identifie

185 IV5/G) protein in the cotton rat and African green monkey models for their replication, immunogenicit

186 pliced exon 10 were identical between human, green monkey, mouse, rat, and pig, while 207 consecutive

187 Adult African green monkeys naturally have low numbers of CD4 T cells

188 mbinant viruses were administered to African green monkeys (NDV-BC and NDV-LS) and rhesus monkeys (ND

189 The infecting SFV originated from an African green monkey (one person) and baboons (three people).

190 African green monkeys, one natural host species, avoid simian AI

191 e describe a genome reference of the African green monkey or vervet (Chlorocebus aethiops).

192 es from a human infected with SFV of African green monkey origin (SFV-3).

193 n of endogenous CRF1 in COS-7 cells (African green monkey origin).

194 tion, RhTRS1 binds to phosphorylated African green monkey PKR.

195 adapted to the polymorphisms of the African Green Monkey population in which it is found.

196 haracterized in plasma from infected African Green monkeys, rabbits, and guinea pigs.

197 Four adult St. Kitts green monkeys received embryonic VM grafts into the rost

198 tion and deletion analysis in BSC-1 (African green monkey, renal epithelial) cells revealed that the

199 cells or established cell lines from African green monkey, rhesus macaque, and baboon.

200 s after intravenous inoculation into African green monkeys, rhesus monkeys, and marmosets.

201 ; the human and, to a low level, the African green monkey sequences bound soluble HCV E2 (sE2) and in

202 eavage-efficient mutant, R-R-R-R, in African green monkeys showed that there was no detectable change

203 Both Vif proteins of HIV-1 and African green monkey simian immunodeficiency virus (SIVagm) bind

204 We now report a novel function of African green monkey simian immunodeficiency virus (SIVagm) Vif

205 only human Apo3G (hApo3G), whereas, African green monkey simian immunodeficiency virus (SIVagm) Vif

206 ian immunodeficiency virus SIV(SM)), African green monkey (SIV(AGM)), and Sykes' monkey (SIV(SYK)) is

207 munodeficiency viruses isolated from African green monkeys (SIVagm) contain a single accessory gene h

208 odeficiency virus (SIV) that infects African green monkeys (SIVagm) contains a vpr homologue, which e

209 Simian immunodeficiency virus from African green monkeys (SIVagm) results in asymptomatic infection

210 onpathogenic infection with SIV from African green monkeys (SIVagm), follicles remain generally virus

211 d simian immunodeficiency virus from African green monkeys (SIVagm), in one round of viral replicatio

212 and simian immunodeficiency virus of African green monkeys (SIVagm).

213 itself, HIV-2 and SIV isolated from African green monkeys (SIVAGM).

214 infects rhesus macaques (SIVmac) and African green monkeys (SIVagm).

215 (simian immunodeficiency virus from African green monkeys [SIVagm] and Rhesus macaques [SIVmac]), th

216 d infection by SIVmac and the SIV of African green monkeys, SIVagm.

217 apped mangabey (SIVrcm), the sabaeus African green monkey (SIVagmSAB), and the chimpanzee (SIVcpz) an

218 odeficiency virus (SIV) that infects African green monkeys (SIVagmTAN), unlike human Apobec3DE, which

219 tion in its sabaeus monkey host, the African green monkey species endemic to West Africa.

220 ne into a demyelinated lesion of the African green monkey spinal cord.

221 developed to measure SIVagm from two African green monkey subspecies demonstrated high levels of SIV

222 ed with that previously observed for African green monkeys, suggesting that the HAE model has potenti

223 African green monkeys systemically immunized with HPV-11 VLPs ex

224 D4(+) T cells of young mandrills and African green monkeys than on those of adults, we propose that l

225 SV neutralization antibody titers in African green monkeys that had been infected previously.

226 Here we show in African green monkeys that systemic delivery of an anti-miRNA ol

227 activities were measured in rat and African green monkey tissues.

228 In this study, we exposed African green monkeys to B. anthracis spores; examined clinical

229 e compared the plasma virome of West African green monkeys to that in their descendants after importa

230 Sixteen St. Kitts African green monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tet

231 Previously, we have shown that African green monkey TRIM5alpha (AgmTRIM5alpha) potently restric

232 We created a panel of African green monkey TRIM5alpha (TRIM5alpha(AGM)) mutants, many

233 east two different retroviruses, and African green monkey TRIM5alpha was able to inhibit infection by

234 In African green monkeys, vaccine-induced serum and mucosal antibod

235 uman foreskin fibroblasts but not in African green monkey (Vero) cells.

236 s in one eye of juvenile rhesus macaques and green monkeys, we combined cDNA subtractions, microarray

237 It was found that all vaccinated African green monkeys were completely protected against subseque

238 HMPV-infected chimpanzees and African green monkeys were highly protected from challenge with

239 otective efficacy in cotton rats and African green monkeys, which are among the best available animal

240 HAV) was originally isolated from an African green monkey with hepatitis and appears to represent a t

241 We infected 35 Asian macaques and African green monkeys with viruses that do or do not express Vpx